Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 7713321)

Published in Diabetologia on February 01, 1995

Authors

P Bottini1, C Tantucci, L Scionti, M L Dottorini, E Puxeddu, G Reboldi, G B Bolli, G Casucci, F Santeusanio, C A Sorbini

Author Affiliations

1: Instituto di Medicina Interna e Scienze Endocrine e Metaboliche, Perugia, Italy.

Articles by these authors

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension (1994) 3.79

Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application. Diabetes Technol Ther (2008) 2.70

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes (2000) 2.32

Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation (2001) 2.10

BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism. J Clin Endocrinol Metab (2007) 1.93

Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension (2000) 1.87

Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84

Arterial oxygen tension in relation to age in healthy subjects. Respiration (1968) 1.84

Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation (1998) 1.83

Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab (1999) 1.78

Androgen receptor mutations in prostate cancer. Cancer Res (2000) 1.74

Insulins today and beyond. Lancet (2001) 1.71

Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68

Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol (1995) 1.65

Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63

Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med (1973) 1.62

The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.61

Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60

Influence of respiratory instability during neurocardiogenic presyncope on cerebrovascular and cardiovascular dynamics. Heart (2007) 1.49

Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab (1999) 1.45

Adrenoleucodystrophy: dermatological findings and skin surface lipid study. Dermatology (1994) 1.39

A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39

Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale. Diabetes Nutr Metab (1999) 1.39

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33

Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J (2003) 1.30

Diabetes and breast cancer risk: a meta-analysis. Br J Cancer (2012) 1.30

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29

Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1996) 1.24

Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23

Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation (2001) 1.22

Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21

Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis (2011) 1.21

Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol (2000) 1.18

A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care (1997) 1.17

The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16

Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax (2002) 1.16

Hypoglycemia in IDDM. Diabetes (1989) 1.15

Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation (1999) 1.15

Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab (2005) 1.15

High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab (1995) 1.14

X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab (1996) 1.14

Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med (1984) 1.14

Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10

Cardiorespiratory intermediate intensive unit: heart-lung interactions. Monaldi Arch Chest Dis (1994) 1.07

Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis (2001) 1.06

Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care (1998) 1.05

Pancreatic alpha-cell function in trauma. JAMA (1974) 1.05

High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med (2001) 1.05

Expiratory flow limitation and orthopnea in massively obese subjects. Chest (2001) 1.04

Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med (1985) 1.03

Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.02

Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Diabetes (1982) 1.02

Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene (2006) 1.02

Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax (2005) 1.01

Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels. Diabetologia (1980) 1.01

Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract (1994) 1.01

Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes (1997) 1.00

Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab (2000) 1.00

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med (2004) 1.00

Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes (1993) 0.99

Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1988) 0.97

Suppressive effect of secretin upon pancreatic alpha cell function. J Clin Invest (1972) 0.97

Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis. J Lab Clin Med (1973) 0.97

Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry (2000) 0.96

A simulation study on a self-tuning portable controller of blood glucose. Int J Artif Organs (1993) 0.96

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care (1993) 0.96

Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest (1997) 0.95

Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest (1992) 0.95

Glucagon: the effects of its excess and deficiency on insulin action. Nutr Metab Cardiovasc Dis (2006) 0.94

Contribution of cortisol to glucose counterregulation in humans. Am J Physiol (1989) 0.94

Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions. J Clin Invest (1984) 0.93

Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes (1996) 0.93

Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. J Am Coll Cardiol (2000) 0.92